Post-operative Healing Following Blepharoplasty and Ptosis Repair

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bausch + Lomb
Bausch + LombNJ - Bridgewater
1 program
Loteprednol etabonate ophthalmic ointmentN/A1 trial
Active Trials
NCT01749241Withdrawn0Est. May 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch + LombLoteprednol etabonate ophthalmic ointment

Clinical Trials (1)

NCT01749241Bausch + LombLoteprednol etabonate ophthalmic ointment

Efficacy of Loteprednol Ointment Following Eyelid Surgery

Start: Sep 2012Est. completion: May 20150
N/AWithdrawn

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space